Obese men are nearly 70% more likely than obese women to develop multiple metabolic problems like high blood pressure and abnormal cholesterol over the next several years, even when accounting for differences in liver fat, activity levels, and insulin resistance.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
A systematic review and meta-analysis could determine whether sex differences in metabolic transition persist across diverse populations after adjusting for body fat distribution, hormones, and lifestyle.
A systematic review and meta-analysis of prospective cohort studies reporting sex-specific hazard ratios for transition from MHO to MUO in obese adults (BMI ≥30 kg/m²), adjusting for waist circumference, liver fat, physical activity, and insulin resistance, across multiple ethnic groups.
An RCT could test whether sex-specific interventions (e.g., testosterone modulation in men, estrogen therapy in postmenopausal women) alter transition risk.
A double-blind RCT of 600 obese adults (BMI ≥30 kg/m²) with MHO, stratified by sex, randomized to testosterone replacement (in men with low levels) or placebo, and estrogen therapy (in postmenopausal women) or placebo, with primary outcome being transition to MUO at 24 months.
A prospective cohort study could determine whether sex differences in fat distribution or hormone levels mediate the association between sex and metabolic transition.
A prospective cohort study following 1000 obese adults (BMI ≥30 kg/m²) aged 40–70 with annual measurement of sex hormones, visceral fat via MRI, and metabolic phenotype over 10 years, adjusting for physical activity and diet.
A case-control study could compare sex-specific metabolic profiles between those who transitioned and those who did not.
A case-control study comparing sex, visceral fat mass, and hormone levels in 200 obese men and 200 obese women who transitioned to MUO within 5 years (cases) versus 200 matched controls who remained metabolically healthy.
A cross-sectional study could describe the prevalence of metabolic syndrome by sex in obese populations.
A cross-sectional study measuring metabolic syndrome components and sex in 1000 obese adults (BMI ≥30 kg/m²) aged 40–70 at a single visit to assess sex differences in prevalence.